Questions of the morphological diagnosis of the malignant neoplasms among children, adolescents and young adults. Experience of the Pathologoanatomic Department of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia
https://doi.org/10.17650/2311-1267-2018-5-2-40-44
Abstract
Morphological study plays a leading role in the diagnosis, the determination of prognosis and the choice of optimal tactics of treatment of malignant neoplasms. But morphological, immunohistochemical and molecular biological diagnostic criteria for tumor pathology is inaccessible to most pathology laboratories in the regions of the Russian Federation. In one third of the cases morphological diagnosis there are errors and inaccuracies. As a result, the choice of the wrong therapeutic strategy leads to a decrease in the overall survival rates. Creation of a system of specialized reference centers for morphological diagnosis of malignant tumors will help to minimize errors. In addition, the systematization of morphological diagnoses within the framework of the national children's population cancer register will allow carrying out oncoepidemiological studies among the children of the Russian Federation. National medical research center of pediatric Hematology, Oncology and immunology named after Dmitry Rogachev is now effectively plays the role of such a centre. During the period 2012–2016 72.361 histological studies, 103.029 immunohistochemical studies, 6507 histochemical studies, 618 studies using in situ hybridization methods were conducted. Material for reference diagnostics was received from 63 territories of the Russian Federation. The increased load on the pathology laboratory staff causes the formation of a system of similar centers of morphological diagnostics with justification of the status, expansion of staff, legal and financial support.
About the Authors
D. M. KonovalovRussian Federation
L. V. Sidorenko
Russian Federation
References
1. Цейтлин Г.Я., Володин Н.Н., Румянцев А.Г. Современные подходы и направления реабилитации детей онкологическими заболеваниями. Вестник восстановительной медицины 2014;5(63):2–9. [Tseitlin G.Ya., Volodin N.N., Roumyantsev A.G. Modern approaches and branches in rehabilitation in paediatric oncology. Vestnik vosstanovitelnoy meditsiny = Journal of Restorative Medicine & Rehabilitation 2014;5(63):2–9. (In Russ.)].
2. Семочкин С.В., Лория С.С., Аршанская А.Г. и др. Десятилетний опыт терапии подростков и лиц молодого возраста с лимфомой Ходжкина по протоколу DAL-HD-90m. Вопросы гематологии/онкологии и иммунопатологии в педиатрии 2007;6(4):22–8. [Semochkin S.V., Loriya S.S., Arshanskaya A.G. et al. Ten years of experience in the therapy of adolescents and young adults with Hodgkin’s lymphoma using the DAL-HD-90m protocol. Voprosy gematologii/onkologii i immunopatologii v pediatrii = Pediatric Hematology/Oncology and Immunopathology 2007;6(4):22–8. (In Russ.)].
3. Shahsiah R., DeKoning J., Samie S. et al. Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory. Pathol Res Pract 2017;213(2):98–105. doi: 10.1016/j. prp.2016.11.016.
4. Криволапов Ю.А., Пешков М.В., Леенман Е.Е. и др. Первый опыт проведения внешнего контроля качества иммуногистохимических исследований в диагностике лимфопролиферативных заболеваний. Архив патологии 2011;73(2):25–32. [Krivolapov Yu.A., Peshkov M.V., Leenman Ye.Ye. et al. The first experience of external quality control of immunohistochemical studies in the diagnosis of lymphoproliferative diseases. Arkhiv patologii = Archive of Pathology 2011;73(2):25–32. (In Russ.)].
5. Юрин А.Г., Ковальский Г.Б. Анализ качества прижизненной диагностики рака почки. Архив патологии 2011;73(2):3–6. [Yurin A.G., Kovalsky G.B. Analysis of the quality of intravital diagnosis of kidney cancer. Arkhiv patologii = Archive of Pathology 2011;73(2):3–6. (In Russ.)].
6. Li X. Pitfalls in the pathological diagnosis of lymphoma. Chin Clin Oncol 2015;4(1):3. doi: 10.3978/j.issn.2304- 3865.2014.11.04.
7. Leeftink A.G., Boucherie R.J., Hans E.W. et al. Predicting turnaround time reductions of the diagnostic track in the histopathology laboratory using mathematical modelling. J Clin Pathol 2016;69(9):793–800. doi: 10.1136/jclinpath-2015-203349.
8. Crothers B.A., Darragh T.M., Tambouret R.H. et al. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire. Arch Pathol Lab Med 2016;140(1):13–21. doi: 10.5858/arpa.2015-0004-CP.
9. «Здравоохранение в России – 2017». Интернет-портал Росстата (http://www. gks.ru/free_doc/doc_2017/zdrav17.pdf). 10. Приказ Министерства здравоохранения Российской Федерации № 179н от 24.03.2016 «О правилах проведения патологоанатомических исследований». 11. Приказ Министерства здравоохранения Российской Федерации № 622 от 11.09.2017 «О сети национальных медицинских исследовательских (научно- практических) центров».
Review
For citations:
Konovalov D.M., Sidorenko L.V. Questions of the morphological diagnosis of the malignant neoplasms among children, adolescents and young adults. Experience of the Pathologoanatomic Department of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of Russia. Russian Journal of Pediatric Hematology and Oncology. 2018;5(2):40-44. (In Russ.) https://doi.org/10.17650/2311-1267-2018-5-2-40-44